Largos supervivientes y terapias dirigidas en melanoma avanzado - page 18

…TOXICITIESASSOCIATEDWITH COBIMETINIB

COMBINEDWITH VEMURAFENIB IN THE

COBRIM STUDY: AN UPDATEDANALYSIS

Brigitte Dréno, et al

CoBRIM: V + C frente a V + placebo

Datos con mediana seguimiento 18’5 meses

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,8,9,10,11,12,13,14,15,16,17 19,20,21,22,23,24,25,26,27,28,...46